Subject: BioMedNet: FDA Divorces Chemistry from Biology Date: Sun, 15 Sep 2002 10:25:07 -0400 FDA maintains two administrative oversight branches for medical products: Center for Biologics Evaluation and Research (CBER)–is responsible for overseeing the safety of bio-tech based therapies, vaccines, blood safety, and gene therapy. Center for Drug Evaluation and…
FDA -Conflicts of Interest to be expanded May 23, 2002 FYI The Washington Post reports that the 1992 Prescription Drug User Fee Act that introduced coporate influence and corporate money into the FDA is about to be renewed and greatly expanded: "There’s no doubt in my mind that bigger and bigger [user fees] harm…
Children in "Hot Demand" for Clinical Trials May 31, 2002 FYI Rachel Zimmerman of The Wall Street Journal reports about the "frenzy" to recruit children for drug trials. The inclusion of children in drug trials allows pharmaceutical companies to cash in on six month patent exclusivity extensions worth hundreds of millions of dollars….
Date: Thu, 30 May 2002 14:14:47 -0400 From: Vera Subject: Bitter Medicine: Pills, Profit & the Public Health_ABC News ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) A Human Rights Organization www.researchprotection.org Contact: Vera Hassner Sharav FYI On May 17 The Wall Street Journal reported (in a front page article) that drug…
Experimentation on Newborns: Is it Ethical? News Stories on Human Research Protection and Commentary by Vera Hassner Sharav May 13, 2002 FYI The Wall Street Journal reported: "One outrage now before a court has stunned even bioethicists who thought they’d seen it all. In 1985, University of Wisconsin (UW) researchers…
Date: Wed, 15 May 2002 12:57:32 -0400 Subject: Harvard President Laments China Study_Globe ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) A Human Rights Organization www.researchprotection.org Contact: Vera Hassner Sharav FYI Harvard’s genetic experiments in rural China have elicited much criticism. In December 2000, The Washington Post published a highly critical investigative…
Pesticide firms want to test chemical toxicity on humans instead of rats Sat, 4 Jan 2003 Count the reasons why not human pesticide experiments: 1) quantum increase in commodification of subjects, 2) presumptive utter absence of benefit to subjects, 3) end term purpose of inquiry is forensic (e.g. the San…
Military proposes serious relaxation of IND regulations Tue, 28 Jan 2003 We are rapidly approaching The Brave New World. FDA bureaucrats are attempting to institutionalize a double standard in human experimentaion by resorting to a strategy of doublespeak. A Department of Defense memo states: “DoD should continue to conduct trials…
Incentives to Pharma Companies but Health Care Leaders Voice Doubts on Smallpox Inoculations Thu, 30 Jan 2003 The New York Times reports (below) that serious doubts about the president’s smallpox vaccination plan emerged at a Senate hearing Wednesday. The Washington Post reports (below) that "The hearing illustrated the growing tensions…
Another Child Devloped Cancer: SCID Trials Suspended – ABC Tue, 14 Jan 2003 ABC News reports that the FDA suspended 30 gene therapy trials after a second child developed leukemia. So far, two boys who had undergone the experimental gene therapy treatment for immunodeficiency, “bubble boy disease” — or SCID–developed…
How Pharma Took Over Medicine: Research and Practice – BMJ / NYT Fri, 3 Jan 2003 In today’s New York Times Dr. Erin Marcus writes: “Medicines aren’t like shampoo or perfume.” But they’re being hawked on TV as if they were just another ‘enhancer’–when in fact, they come with glossed…
Instead of a War against Drugs, Children Riddled with Psych Drugs Tue, 14 Jan 2003 In his 1994 book, The War on Children, psychiatrist, Dr. Peter Breggin exposed the practice of prescribing psychiatric drugs as a method for controlling children’s behavior. Dr. Breggin was reviled by the psychiatric establishment, even…
